Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

322 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real-Life Setting.
Gatto M, Saccon F, Zen M, Regola F, Fredi M, Andreoli L, Tincani A, Urban ML, Emmi G, Ceccarelli F, Conti F, Bortoluzzi A, Govoni M, Tani C, Mosca M, Ubiali T, Gerosa M, Bozzolo E, Canti V, Cardinaletti P, Gabrielli A, Tanti G, Gremese E, De Marchi G, De Vita S, Fasano S, Ciccia F, Pazzola G, Salvarani C, Negrini S, Puppo F, Di Matteo A, De Angelis R, Orsolini G, Rossini M, Faggioli P, Laria A, Piga M, Mathieu A, Scarpato S, Rossi FW, de Paulis A, Brunetta E, Ceribelli A, Selmi C, Prete M, Racanelli V, Vacca A, Bartoloni E, Gerli R, Larosa M, Iaccarino L, Doria A. Gatto M, et al. Among authors: di matteo a. Arthritis Rheumatol. 2020 Aug;72(8):1314-1324. doi: 10.1002/art.41253. Epub 2020 Jun 12. Arthritis Rheumatol. 2020. PMID: 32275125
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study.
Iaccarino L, Andreoli L, Bocci EB, Bortoluzzi A, Ceccarelli F, Conti F, De Angelis R, De Marchi G, De Vita S, Di Matteo A, Emmi G, Emmi L, Gatto M, Gerli R, Gerosa M, Govoni M, Larosa M, Meroni PL, Mosca M, Pazzola G, Reggia R, Saccon F, Salvarani C, Tani C, Zen M, Frigo AC, Tincani A, Doria A. Iaccarino L, et al. Among authors: di matteo a. J Autoimmun. 2018 Jan;86:1-8. doi: 10.1016/j.jaut.2017.09.004. Epub 2017 Sep 19. J Autoimmun. 2018. PMID: 28935492
Imaging of Joint and Soft Tissue Involvement in Systemic Lupus Erythematosus.
Di Matteo A, Smerilli G, Cipolletta E, Salaffi F, De Angelis R, Di Carlo M, Filippucci E, Grassi W. Di Matteo A, et al. Among authors: di carlo m. Curr Rheumatol Rep. 2021 Jul 16;23(9):73. doi: 10.1007/s11926-021-01040-8. Curr Rheumatol Rep. 2021. PMID: 34269905 Free PMC article. Review.
Impact of disease duration and gender on the sensitivity and specificity of 2015 ACR/EULAR classification criteria for gout. Cross-sectional results from an Italian multicentric study on the management of crystal-induced arthritis (ATTACk).
Lorenzin M, Ughi N, Ariani A, Raffeiner B, Ceccarelli F, Lucchetti R, Bortoluzzi A, Cimmino MA, Di Matteo A, Frallonardo P, Hoxha A, Ortolan A, Favero M, Parisi S, Furini F, Zanetti A, Carrara G, Scirè CA, Doria A, Ramonda R; SIR Study Group ATTACk. Lorenzin M, et al. Among authors: di matteo a. Clin Exp Rheumatol. 2022 Jul;40(7):1368-1377. doi: 10.55563/clinexprheumatol/4rrgyt. Epub 2021 Sep 28. Clin Exp Rheumatol. 2022. PMID: 34665701 Free article.
322 results